Inscrição YC de Humane Genomics

Summer 2021Active

Humane Genomics passou pela Y Combinator no batch Summer 2021 como uma empresa Healthcare. Abaixo: o que a empresa faz, quem a fundou e sua inscrição para a YC, reconstruída pergunta por pergunta no formulário real da YC.

Batch YC: Summer 2021
Indústria: HealthcareTherapeutics
Tamanho da equipe: 5
Status: Active
Lançada: 2021

Fundadores

Peter WeijmarshausenFounder
Chad MolesFounder

O que Humane Genomics faz

Humane Genomics has developed a platform to engineer cancer killing viruses. We have taken a first principles approach to design and make oncolytic viral therapies. Using a highly lytic RNA virus engineered with "2 factor authentication" (using selective infection and selective replication) they have an on-target to off-target kill ratio > 1000. We are working on our first indication, pediatric liver cancer (hepatoblastoma), with our partners at Texas Children's Hospital, who are world leading experts. We have in vivo (mouse) data showing safety and currently developing efficacy data and are showing 50% reduction in tumor volume.

Inscrição YC de Humane Genomics, reconstruída

Inscrição Y Combinator

Humane Genomics, lote Summer 2021. As verdadeiras perguntas do formulário, respondidas com dados públicos.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Humane Genomics

Describe what your company does in 50 characters or less.

Platform to make artificial viruses for cancer

What is your company going to make? Please describe your product and what it does or will do.

We have built a platform that designs and produces oncolytic RNA viruses that selectively kill cancer cells. Our virus uses two independent targeting mechanisms - selective infection and selective replication - to keep healthy cells safe while attacking tumors. Right now, we're applying this tech to pediatric liver cancer and working with Texas Children's Hospital to validate safety and efficacy in animal models.

Where do you live now, and where would the company be based after YC?

We live in New York, NY, and plan to base the company there after YC as well.

Explain your decision regarding location.

We are based in New York because that's where our team is and where we've built our lab and partnerships. It makes sense to stay where we have existing infrastructure and clinical collaborators.

21 respostas a mais na inscrição completa

Founders, Progress, Idea, Equity, Curious, Batch Preference estão na versão completa. Crie uma conta gratuita para abri-la no YC Insights, ao lado de todos os outros batches da YC.

Ver inscrição completa

Perguntas Frequentes

Esta é a inscrição real da YC de Humane Genomics?

Não. A Y Combinator mantém as inscrições submetidas em privado. Esta é uma reconstrução: as perguntas reais do formulário da YC, respondidas a partir dos dados públicos de Humane Genomics (notas de lançamento, históricos de fundadores, descrição do produto). Mostra como uma empresa como Humane Genomics se apresentaria à YC, não o texto que eles submeteram.

Em qual batch da YC Humane Genomics esteve?

Humane Genomics fez parte do batch Summer 2021 da Y Combinator.

Quem fundou o Humane Genomics?

O Humane Genomics foi fundado por Peter Weijmarshausen, Chad Moles.

O que o Humane Genomics faz?

A platform to make artificial viruses as cancer therapeutics.

Como eu leio o application completo reconstruído?

Crie uma conta gratuita no Round Funded. A versão completa de 26 respostas do application do Humane Genomics, e de todos os outros lotes do YC, está no YC Insights.